Exide Industries Limited (BOM:500086)

CTI BioPharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	323,425	306,298	258,825	151,300	128,393	156,018
Market Cap Growth	18.34%	18.34%	71.07%	17.84%	-17.71%	39.85%
Enterprise Value	338,808	320,043	252,108	143,677	116,592	139,117
Last Close Price	380.50	358.47	301.79	175.00	148.51	178.35
PE Ratio	40.68	38.53	29.52	18.39	2.94	19.26
Forward PE	25.63	18.20	18.20	18.20	18.20	18.20
PS Ratio	1.88	1.78	1.54	1.00	1.00	1.51
PB Ratio	2.32	2.20	2.01	1.36	1.21	2.13
P/TBV Ratio	2.38	2.25	2.05	1.40	1.23	2.37
P/FCF Ratio	-	-	-	-	-	8.82
P/OCF Ratio	25.41	24.06	16.88	19.69	209.62	6.89
PEG Ratio	-	1.09	1.09	1.09	1.09	1.09
EV/Sales Ratio	1.97	1.86	1.50	0.95	0.91	1.34
EV/EBITDA Ratio	18.94	18.16	14.18	9.23	8.52	10.41
EV/EBIT Ratio	27.86	26.33	20.02	13.21	12.14	14.35
EV/FCF Ratio	-50.13	-	-	-	-	7.86
Debt / Equity Ratio	0.14	0.14	0.09	0.06	0.05	0.07
Debt / EBITDA Ratio	1.13	1.13	0.62	0.41	0.37	0.38
Debt / FCF Ratio	-	-	-	-	-	0.29
Asset Turnover	0.87	0.87	1.02	1.05	0.60	0.39
Inventory Turnover	2.77	2.77	3.14	3.31	3.18	2.66
Quick Ratio	0.40	0.40	0.48	0.69	0.75	0.70
Current Ratio	1.23	1.23	1.41	1.88	1.82	1.30
Return on Equity (ROE)	5.97%	5.97%	7.34%	7.56%	7.74%	10.60%
Return on Assets (ROA)	3.84%	3.84%	4.78%	4.74%	2.82%	2.28%
Return on Capital (ROIC)	5.07%	5.07%	6.10%	5.93%	6.33%	8.33%
Return on Capital Employed (ROCE)	7.80%	7.80%	9.20%	9.30%	8.70%	4.10%
Earnings Yield	2.46%	2.60%	3.39%	5.44%	34.01%	5.19%
FCF Yield	-2.09%	-2.21%	-1.32%	-1.49%	-4.71%	11.34%
Dividend Yield	0.52%	0.56%	0.66%	1.14%	1.35%	1.12%
Payout Ratio	21.38%	21.38%	19.39%	-	3.89%	20.99%
Total Shareholder Return	0.52%	0.56%	0.66%	1.14%	1.35%	1.12%

Updated Jan 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.